Evidence map›Paper›PMID 25788677›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activity.

David A Slattery, Roshan R Naik, Thomas Grund, Yi-Chun Yen, Simone B Sartori, Andrea Füchsl, Beate C Finger, Betina Elfving, Uwe Nordemann, Remo Guerrini and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. A Role for Neuropeptide S in Alcohol and Cocaine Seeking.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 6 countries.

David A SlatteryDepartment of Behavioral and Molecular Neurobiology, and.ORCID http://orcid.org/0000-0001-8753-5005
Roshan R NaikDepartment of Behavioral and Molecular Neurobiology, and Max Planck Institute of Psychiatry, 80804 Munich, Germany.
Thomas GrundDepartment of Behavioral and Molecular Neurobiology, and.
Yi-Chun YenMax Planck Institute of Psychiatry, 80804 Munich, Germany.
Simone B SartoriDepartment of Pharmacology and Toxicology, University of Innsbruck, 6020 Innsbruck, Austria.
Andrea FüchslDepartment of Behavioral and Molecular Neurobiology, and.
Beate C FingerDepartment of Behavioral and Molecular Neurobiology, and.
Betina ElfvingTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, DK-8000 Aarhus, Denmark.ORCID http://orcid.org/0000-0001-6939-5088
Uwe NordemannFaculty of Chemistry and Pharmacy, University of Regensburg, 93040 Regensburg, Germany.
Remo GuerriniDepartment of Chemistry and Pharmaceutical Sciences and Laboratorio per le Tecnologie delle Terapie Avanzate, University of Ferrara, 44100 Ferrara, Italy.
Girolamo CaloDepartment of Medical Sciences, Section of Pharmacology, National Institute of Neuroscience, University of Ferrara, 44121 Ferrara, Italy.ORCID http://orcid.org/0000-0001-5436-959X
Gregers WegenerTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, DK-8000 Aarhus, Denmark, Pharmaceutical Centre of Excellence, School of Pharmacy, North West University, Potchefstroom, 2520, South Africa.
Aleksander A MathéClinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden, and.
Nicolas SingewaldDepartment of Pharmacology and Toxicology, University of Innsbruck, 6020 Innsbruck, Austria.
Ludwig CzibereMax Planck Institute of Psychiatry, 80804 Munich, Germany.
Rainer LandgrafMax Planck Institute of Psychiatry, 80804 Munich, Germany.
Inga D NeumannDepartment of Behavioral and Molecular Neurobiology, and inga.neumann@biologie.uni-regensburg.de.
Max Planck Institute of Psychiatry · DEAarhus University · DKUniversität Innsbruck · ATUniversity of Ferrara · ITUniversity of Regensburg · DEKarolinska Institutet · SE

Funding

Austrian Science Fund FWF P 25375
6 · The paper itself

Abstract

Neuropeptide S (NPS) has generated substantial interest due to its anxiolytic and fear-attenuating effects in rodents, while a corresponding receptor polymorphism associated with increased NPS receptor (NPSR1) surface expression and efficacy has been implicated in an increased risk of panic disorder in humans. To gain insight into this paradox, we examined the NPS system in rats and mice bred for high anxiety-related behavior (HAB) versus low anxiety-related behavior, and, thereafter, determined the effect of central NPS administration on anxiety- and fear-related behavior. The HAB phenotype was accompanied by lower basal NPS receptor (Npsr1) expression, which we could confirm via in vitro dual luciferase promoter assays. Assessment of shorter Npsr1 promoter constructs containing a sequence mutation that introduces a glucocorticoid receptor transcription factor binding site, confirmed via oligonucleotide pull-down assays, revealed increased HAB promoter activity-an effect that was prevented by dexamethasone. Analogous to the human NPSR1 risk isoform, functional analysis of a synonymous single nucleotide polymorphism in the coding region of HAB rodents revealed that it caused a higher cAMP response to NPS stimulation. Assessment of the behavioral consequence of these differences revealed that intracerebroventricular NPS reversed the hyperanxiety of HAB rodents as well as the impaired cued-fear extinction in HAB rats and the enhanced fear expression in HAB mice, respectively. These results suggest that alterations in the NPS system, conserved across rodents and humans, contribute to innate anxiety and fear, and that HAB rodents are particularly suited to resolve the apparent discrepancy between the preclinical and clinical findings to date.

Indexed as

BreedingAcoustic StimulationAnimalsAnxietyFearHEK293 CellsHumansMaleMicePolymorphism, Single NucleotideRatsReceptors, G-Protein-CoupledNPSR1 protein, mouseReceptors, G-Protein-Coupledanxietybasolateral amygdalafearparaventricular nucleuspromoter fragmentation

Identifiers

PMID25788677
PMCPMC6605130
OpenAlexW2052605228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.